Drugs used for euthanasia in Flanders, Belgium

被引:13
作者
Vander Stichele, RH
Bilsen, JJR
Bernheim, JL
Mortier, F
Deliens, L
机构
[1] State Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium
[2] Vrije Univ Amsterdam, Med Ctr, Inst Res Extramural Med, Dept Social Med, Amsterdam, Netherlands
[3] Free Univ Brussels, Dept Human Ecol, Brussels, Belgium
[4] State Univ Ghent, Ctr Environm Philosophy & Bioeth, B-9000 Ghent, Belgium
[5] Free Univ Brussels, Dept Med Sociol & Hlth Sci, Brussels, Belgium
关键词
euthanasia; active; narcotics; neuromuscular nondepolarising agents; Belgium; prevalence; catchment area (health); drug utilisation; questionnaires; practice guidelines;
D O I
10.1002/pds.863
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose Our aim was to describe and assess the medicinal products and doses used for euthanasia in a series of cases, identified within an epidemiological death certificate study in Belgium, where euthanasia was until recently legally forbidden and where guidelines for euthanasia are not available. Methods In a random sample of the deaths in 1998 in Belgium, the physicians who signed the death certificates were identified and sent an anonymous mail questionnaire. The questionnaires of the deaths classified as euthanasia cases were reviewed by a multi-disciplinary panel. Results A total of 22 among 1925 questionnaires pertained to voluntary euthanasia. In 17 cases, detailed information on the euthanatics (medicinal substances used for euthanasia) used was provided. Opioids were used in 13 cases (in 7 as a single drug). Time between last dose and expiry ranged from 4 to 900 min. The panel judged that only in 4 cases effective euthanatics were used. Conclusions In the end-of-life decision cases perceived by Belgian physicians as euthanasia, pharmacological practices were disparate, although dominated by the use of morphine, in the very late phase of dying, in doses which were unlikely to be lethal. Most physicians clandestinely engaging in euthanasia in Belgium seemed unaware of procedures for guaranteeing a quick, mild and certain death. Information on the pharmacological aspects of euthanasia should be included in the medical curriculum and continuing medical education, at least in countries with a legal framework permitting euthanasia under specified conditions. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 30 条
[1]  
Admiraal P V, 1995, Ned Tijdschr Geneeskd, V139, P265
[2]  
BATTIN MP, 1996, DRUG USE ASSISTED SU
[3]  
BUCHAN ML, 1995, J CLIN ETHIC, V6, P53
[4]   UK geriatricians' attitudes to active voluntary euthanasia and physician-assisted death [J].
Clark, D ;
Dickinson, G ;
Lancaster, CJ ;
Noble, TW ;
Ahmedai, SH ;
Philp, I .
AGE AND AGEING, 2001, 30 (05) :395-398
[5]   End-of-life decisions in medical practice in Flanders, Belgium: a nationwide survey [J].
Deliens, L ;
Mortier, F ;
Bilsen, J ;
Cosyns, M ;
Vander Stichele, R ;
Vanoverloop, J ;
Ingels, K .
LANCET, 2000, 356 (9244) :1806-1811
[6]   Practical issues in physician-assisted suicide [J].
Drickamer, MA ;
Lee, MA ;
Ganzini, L .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (02) :146-151
[7]   Attitudes and practices of US oncologists regarding euthanasia and physician-assisted suicide [J].
Emanuel, EJ ;
Fairclough, D ;
Clarridge, BC ;
Blum, D ;
Bruera, E ;
Penley, WC ;
Schnipper, LE ;
Mayer, RJ .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (07) :527-532
[8]   Patients' views about physician participation in assisted suicide and euthanasia [J].
Graber, MA ;
Levy, BI ;
Weir, RF ;
Oppliger, RA .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (02) :71-76
[9]   Clinical problems with the performance of euthanasia and physician-assisted suicide in the netherlands. [J].
Groenewoud, JH ;
van der Heide, A ;
Onwuteaka-Philipsen, BD ;
Willems, DL ;
van der Maas, PJ ;
van der Wal, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) :551-556
[10]  
Horikx A, 2000, Ned Tijdschr Geneeskd, V144, P2497